Chronic Rhinosinusitis Without Nasal Polyps Clinical Trial
Official title:
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps - The BiRCh Study
The primary purpose of the study is to evaluate the efficacy of brensocatib at 10 and 40 milligrams (mg) once daily (QD) compared with placebo in improving clinical symptoms of CRSsNP.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06069310 -
Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic Asthma
|
||
| Active, not recruiting |
NCT05553951 -
Adherence in Global Airways
|
N/A | |
| Active, not recruiting |
NCT06118554 -
3D Printing to Improve Nasal Irrigation Outcome
|
N/A | |
| Not yet recruiting |
NCT06398873 -
Effect of Dupilumab on Nasal Epithelial Barrier Function in Patients With CRSwNP
|
||
| Withdrawn |
NCT04158596 -
Safety and Efficacy of SDX-3101 for the Treatment of Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
|
N/A | |
| Recruiting |
NCT05642806 -
Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab Treatment
|
Phase 4 | |
| Completed |
NCT04678856 -
Dupilumab in CRSsNP
|
Phase 2 | |
| Terminated |
NCT01676415 -
Corticosteroid Therapy for Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
|
Phase 4 | |
| Recruiting |
NCT05843019 -
Adherence in Global Airways - Steroid Intake and Effects on Chronic Rhinosinosinutis
|